Abstract
The 2013 American College of Cardiology and the American Heart Association guidelines recommended the Pooled Cohort equations for evaluation of cardiovascular (CV) risk of individuals. We investigated the usefulness of the Pooled Cohort equations in Chinese by validating this risk prediction model using the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort. The Hong Kong CRISPS is a population-based prospective cohort study of CV risk factors among 2895 Chinese men and women (aged 25-74 years) initiated in 1995. CV events were ascertained until December 2012. The discrimination and calibration of the Pooled Cohort equations were evaluated and compared with the Framingham CV risk equation. A Hosmer-Lemeshow chi-square statistic (X(2)) of <20 indicated good calibration. The discrimination power of the 2 models in both men and women was moderate. The calibration score of both models were unacceptable in men (Pooled Cohort X(2), 24.1; Framingham X(2), 20.1), but was satisfactory in women (10.1 and 12.1, respectively). In men, with recalibration of the model using the CRISPS data, the accuracy of prediction improved. Recalibration, however, could not be applied to the Pooled Cohort model because the degree of mis...Continue Reading
References
Dec 24, 1997·Clinical and Experimental Pharmacology & Physiology·E D Janus
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Jing LiuDong Zhao
Jan 20, 2007·Journal of Epidemiology and Community Health·F BarziM Woodward
Jan 31, 2007·The American Journal of Cardiology·James K Liao
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Feb 28, 2013·European Heart Journal·UNKNOWN HPS2-THRIVE Collaborative Group
Jun 12, 2013·Pharmacogenomics·Miao Hu, Brian Tomlinson
Nov 14, 2013·Circulation·David C GoffGordon F Tomaselli
Nov 26, 2013·Lancet·Paul M Ridker, Nancy R Cook
Apr 1, 2014·JAMA : the Journal of the American Medical Association·Maryam KavousiOscar H Franco
Apr 1, 2014·JAMA : the Journal of the American Medical Association·Paul MuntnerMonika M Safford
Jul 1, 2014·Current Opinion in Lipidology·G Michael AllanJames McCormack
Feb 13, 2015·European Journal of Clinical Pharmacology·Bruce K BirminghamHelen J Ambrose
Feb 17, 2015·Annals of Internal Medicine·Andrew P DeFilippisMichael J Blaha
Citations
May 18, 2016·Mayo Clinic Proceedings·Paul D Loprinzi, Ovuokerie Addoh
Oct 6, 2016·Postgraduate Medicine·Meghan K EdwardsPaul D Loprinzi
Dec 9, 2016·Medicine·Vidya P MenonVeena Menon
Sep 30, 2016·Circulation·Xueli YangDongfeng Gu
Apr 26, 2017·Journal of the American Heart Association·Julian WolfsonPatrick J O'Connor
Dec 28, 2018·Circulation·Donald M Lloyd-JonesRoger S Blumenthal
Jan 18, 2020·Diabetes & Metabolism Journal·Jae Hyun BaeMoon Kyu Lee
Jun 14, 2019·BMC Medicine·Johanna A DamenThomas P A Debray
Nov 6, 2018·BioMed Research International·Qiuan ZhongLiuren Meng
Jul 12, 2019·Journal of the American Heart Association·Fatima RodriguezLatha P Palaniappan
Oct 1, 2020·BMC Public Health·Yunxing JiangShuxia Guo
Jan 5, 2021·International Journal of Epidemiology·David Tak Wai LuiUNKNOWN Hong Kong Cardiovascular Risk Factor Prevalence Study Group
Mar 5, 2019·American Heart Journal·Xun TangYonghua Hu
Jun 7, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Yue ZhangGenming Zhao
Jun 18, 2021·Clinical Epidemiology·Yunxing JiangHeng Guo
Jul 14, 2021·Scientific Reports·Sung Hyouk ChoiHyung-Jin Yoon
Jul 4, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Christopher L SchaichTimothy M Hughes
Oct 11, 2021·Clinical Epigenetics·Yujing XiaJordana T Bell